Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
3 Biotech Stocks That Could Have Investors Grinning Soon
01:54pm, Friday, 02'nd Aug 2024
Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their inves
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
08:00am, Friday, 02'nd Aug 2024
Amgen is developing a promising anti-obesity candidate. This product could be a blockbuster by 2030.
Amgen (AMGN) Advances While Market Declines: Some Information for Investors
06:51pm, Thursday, 01'st Aug 2024
Amgen (AMGN) closed at $335.53 in the latest trading session, marking a +0.92% move from the prior day.
AMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTS
04:00pm, Thursday, 01'st Aug 2024
THOUSAND OAKS, Calif. , Aug. 1, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2024 financial results on Tuesday, August 6, 2024, after the close of th
Exploring Analyst Estimates for Amgen (AMGN) Q2 Earnings, Beyond Revenue and EPS
10:20am, Thursday, 01'st Aug 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
The Top 3 Biotech Stocks to Buy Now Summer 2024
04:30pm, Wednesday, 31'st Jul 2024
In the bustling world of biotechnology, innovation remains the cornerstone of growth. Some biotech stocks, known for their groundbreaking research and rapid adaptation to health challenges, are partic
Can Amgen (AMGN) Keep the Beat Streak Alive in Q2 Earnings?
10:32am, Wednesday, 31'st Jul 2024
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
11:07am, Tuesday, 30'th Jul 2024
Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Biotech Names With Potential Catalysts By Year End
03:32pm, Monday, 29'th Jul 2024
The huge sector rotation we have seen in the market over the past few weeks has significantly benefited the SPDR® S&P Biotech ETF. If this trend continues, small-cap names within the sector should co
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
01:37pm, Monday, 29'th Jul 2024
Four pharmaceutical companies involved in the first U.S. negotiations over prices for the Medicare program said they do not expect a significant impact on their businesses after seeing confidential su
Amgen (AMGN) Advances But Underperforms Market: Key Facts
06:56pm, Friday, 26'th Jul 2024
In the closing of the recent trading day, Amgen (AMGN) stood at $334.85, denoting a +0.16% change from the preceding trading day.
3 Fabulous Growth Stocks to Buy and Hold Forever
03:40pm, Wednesday, 24'th Jul 2024
Investors have been on a roller coaster ride for the past four years. One of the longest bull markets in history was brought to a screeching halt by the global pandemic.
7 Biotech Stocks to Keep on Your Clinical Radar
02:57pm, Tuesday, 23'rd Jul 2024
Initially, I had every intention to write a cookie-cutter assessment of intriguing biotech stocks; that is, I wanted to say that enterprises within this specialized healthcare field will always be rel
3 Stocks That Are Melting Up. Is There Room to Run?
01:23pm, Tuesday, 23'rd Jul 2024
Occasionally, hot stocks can get that much hotter in a move that can only be described as a “melt-up.” Such extreme share price action can be like the reverse of a stock meltdown, whereby a stock
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 23'rd Jul 2024
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
